UBS AM
CVET

UBS AM’s Covetrus, Inc. Common Stock CVET Stock Holding History

UBS AM’s Portfolio CVET Stock Details CVET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-150,629
Closed -$3.13M – 2788
2022
Q2 		$3.13M Buy
150,629
+33,261
+28% +$592K ﹤0.01% 1416
2022
Q1 		$1.97M Hold
117,368
– – ﹤0.01% 1806
2021
Q4 		$2.34M Sell
117,368
-1,587
-1% -$29.9K ﹤0.01% 1793
2021
Q3 		$2.16M Sell
118,955
-9,883
-8% -$227K ﹤0.01% 1805
2021
Q2 		$3.48M Buy
128,838
+3,082
+2% +$86.2K ﹤0.01% 1570
2021
Q1 		$3.77M Buy
125,756
+19,902
+19% +$679K ﹤0.01% 1470
2020
Q4 		$3.04M Buy
105,854
+5,860
+6% +$158K ﹤0.01% 1513
2020
Q3 		$2.44M Buy
99,994
+16,016
+19% +$345K ﹤0.01% 1469
2020
Q2 		$1.5M Sell
83,978
-73,531
-47% -$966K ﹤0.01% 1631
2020
Q1 		$1.28M Buy
157,509
+17,613
+13% +$201K ﹤0.01% 1595
2019
Q4 		$1.85M Sell
139,896
-11,443
-8% -$139K ﹤0.01% 1639
2019
Q3 		$1.8M Buy
151,339
+9,324
+7% +$173K ﹤0.01% 1657
2019
Q2 		$3.47M Buy
142,015
+40,858
+40% +$1.18M ﹤0.01% 1347
2019
Q1 		$3.22M Buy
+101,157
New +$3.59M ﹤0.01% 1313

Other funds holding CVET

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS AM's CVET Position: Q3 2022 in Review

UBS AM sold out of Covetrus, Inc. Common Stock (CVET) in Q3 2022, closing a stake of 150,629 shares — an estimated $3.13M sold.

UBS AM first reported a position in CVET in Q1 2019 and held it in 14 quarters. The position peaked at $3.77M in Q1 2021. 250 funds tracked by Wall St. Rank hold CVET as of Q3 2022.

  • UBS AM reported no remaining Covetrus, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • UBS AM sold 150,629 Covetrus, Inc. Common Stock shares in Q3 2022, an estimated $3.13M.
  • UBS AM first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 14 quarters.
  • UBS AM's Covetrus, Inc. Common Stock position peaked at $3.77M in Q1 2021.
  • 250 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q3 2022.

Based on UBS AM's 13F filing for Q3 2022, filed 14 Nov 2022.